KLRK1 and colorectal cancer: NKG2D ligands are present in tumor cells of various origins including colorectal cancer, ovarian carcinoma, pancreatic cancer, prostate cancer, acute lymphoblastic leukemia, lymphomas, and in a range of cancer cell lines indicating their use for both hematological and solid tumors (165, 166).